oxazoles has been researched along with Androgen-Independent Prostatic Cancer in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, Y; He, M; Peng, Y; Qu, F; Sun, J; Wang, G; Wang, Q; Zhou, F | 1 |
| Chen, C; Gao, X; Hou, J; Ren, S; Sun, Y; Wang, F; Wang, M; Xu, C; Xu, W; Yan, H; Yang, B; Yang, Q; Zhang, W; Zhou, Q; Zhou, T | 1 |
| Ameratunga, M; Aspegren, J; Bono, P; Braña, I; de Bono, JS; Korjamo, T; Plummer, R; Postel-Vinay, S; Snapir, A | 1 |
| Bogdan, D; Brooks, N; Brown, R; Carreira, S; Chand, SN; Crespo, M; de Bono, JS; Ferreira, A; Figueiredo, I; Gil, VS; Gurel, B; Harbottle, GW; Knudsen, KE; Lane, J; McNair, C; Miranda, S; Neeb, AJ; Ning, J; Onions, S; Pal, A; Paoletta, S; Pegg, N; Pereira, R; Prosser, A; Raja, M; Rekowski, J; Riisnaes, R; Schiewer, MJ; Shannon, J; Sharp, A; Smyth, D; Swain, A; Taddei, D; Thomson, S; Tunariu, N; Welti, J; West, W; Worthington, J; Young, B; Yuan, W | 1 |
2 trial(s) available for oxazoles and Androgen-Independent Prostatic Cancer
| Article | Year |
|---|---|
Preclinical profile and phase I clinical trial of a novel androgen receptor antagonist GT0918 in castration-resistant prostate cancer.
Topics: Aged; Animals; Apoptosis; Cell Proliferation; Follow-Up Studies; Humans; Male; Maximum Tolerated Dose; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Oxazoles; Prognosis; Prostatic Neoplasms, Castration-Resistant; Thiohydantoins; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2020 |
First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents; Biological Availability; Blood Platelets; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Fatigue; Female; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Maximum Tolerated Dose; Melanoma; Middle Aged; Neoplasms; Ovarian Neoplasms; Oxazoles; Prostatic Neoplasms, Castration-Resistant; Proteins; Pyridines; Quinolines; Sarcoma; Small Cell Lung Carcinoma; Young Adult | 2020 |
2 other study(ies) available for oxazoles and Androgen-Independent Prostatic Cancer
| Article | Year |
|---|---|
Metabolomic profiling to evaluate the efficacy of proxalutamide, a novel androgen receptor antagonist, in prostate cancer cells.
Topics: Amino Acids; Androgen Receptor Antagonists; Anilides; Benzamides; Cell Line, Tumor; Cell Survival; Glutathione; Humans; Male; Metabolome; Metabolomics; Nitriles; Nucleosides; Oxazoles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Thiohydantoins; Tosyl Compounds | 2020 |
Targeting the p300/CBP Axis in Lethal Prostate Cancer.
Topics: Androgen Receptor Antagonists; Animals; Cell Line, Tumor; Cell Proliferation; Humans; Imidazoles; Male; Mice; Oxazoles; p300-CBP Transcription Factors; Prostatic Neoplasms, Castration-Resistant; Xenograft Model Antitumor Assays | 2021 |